Fairfax Financial Holdings’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-67,400
Closed -$6.54M 45
2019
Q3
$6.54M Buy
67,400
+55,800
+481% +$5.59M 0.3% 14
2019
Q2
$1.19M Hold
11,600
0.05% 27
2019
Q1
$1.32M Buy
+11,600
New +$853K 0.05% 25

Fairfax Financial Holdings's ONCE Position: Q4 2019 in Review

Fairfax Financial Holdings sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2019, closing a stake of 67,400 shares — an estimated $6.54M sold.

Fairfax Financial Holdings first reported a position in ONCE in Q1 2019 and held it in 3 quarters. The position peaked at $6.54M in Q3 2019. 0 funds tracked by Wall St. Rank hold ONCE as of Q4 2019.

  • Fairfax Financial Holdings reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
  • Fairfax Financial Holdings sold 67,400 Spark Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $6.54M.
  • Fairfax Financial Holdings first reported a position in Spark Therapeutics, Inc. Common Stock in Q1 2019 and held it in 3 quarters.
  • Fairfax Financial Holdings's Spark Therapeutics, Inc. Common Stock position peaked at $6.54M in Q3 2019.
  • 0 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2019.

Based on Fairfax Financial Holdings's 13F filing for Q4 2019, filed 14 Feb 2020.